We report the development of a blood test measuring four proteins (macrophage migration inhibitory factor, osteopontin, prolactin and cancer antigen 125), which can distinguish ovarian cancer samples, even early-stage disease, from healthy samples in the population tested. The gene discussed is MIF; the disease is ovarian cancer.